Eylea 2 mg/0.05 ml, Injektionslösung in einer Fertigspritze

7680623930026 CH-62393 Injektionslösung

Associated product:

EYLEA sol inj 2 mg/0.05ml ser pré
Eylea 2 mg/0.05 ml, Injektionslösung in einer Fertigspritze
Eylea 2 mg/0.05 ml, Injektionslösung in einer Fertigspritze
1 / 2
google

Article details

Package size
1
Selling units
1
Measure
Fertigspritze(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
08/10/2025
Summary of Product Characteristics
Français
08/10/2025
Summary of Product Characteristics
Italien
08/10/2025

Detailed composition

Substance Quantity Type Category
(N/A)
2.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
60.0 UG Substance HBESI

Reimbursement information

Public price
CHF 936.40
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/05/2020

Authorization holder

Bayer (Schweiz) AG

8045 Zürich

Authorization information

Swissmedic authorization number
62393
Drug name
Eylea, Injektionslösung zur Intravitrealen Anwendung in einer Fertigspritze
Galenic form
LSINJ
ATC Code
S01LA05
Authorization status
Z
Dispensing category
B
First authorization
29/10/2012
Authorization expiration date
31/12/9999
IT Number
11.99.0.
Domain
Human medicine
Field of application
2mg/0,05 ml: Exsudative (feuchte) altersbezogenen Makuladegeneration (AMD). Makulaödem infolge eines retinalen Zentralvenenverschlusses (CRVO) und retinalen Venenastverschlusses (BRVO), diabetisches Makulaödem (DME), Behandlung von subfovealen und juxtafovealen choroidalen Neovaskularisationen infolge einer pathologischen Myopie (mCNV). Behandlung der Frühgeborenen-Retinopathie bei Frühgeborenen (ROP). 8 mg/0.07 ml: AMD und DME

Package details

Description (FR)
EYLEA sol inj 2 mg/0.05ml ser pré
Description (DE)
EYLEA Inj Lös 2 mg/0.05ml Fertspr
Market launch
29/10/2012
Narcotic (BTM)
No

Other package sizes (2)

EYLEA sol inj 2 mg/0.05ml ser prê 0.05 ml
None None
GTIN: 7680623930019
Not in V1
EYLEA sol inj 8 mg/0.07ml ser prê
1 FESP
GTIN: 7680623930033
View